Advent Capital Management HALOZYME THERAPEUTICS IN Transaction History

Advent Capital Management

16,930,000

Previous 16,045,000 5.52%

Previous $0 NaN%

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	N/A	885,000 Added 5.52%	16,930,000 $0
Q1 2025 May 12, 2025	SELL	N/A	-3,820,000 Reduced 19.23%	16,045,000 $0
Q4 2024 Feb 13, 2025	SELL	N/A	-143,000 Reduced 0.71%	19,865,000 $0
Q3 2024 Nov 13, 2024	BUY	N/A	20,008,000 New	20,008,000 $0
Q3 2023 Nov 13, 2023	BUY	N/A	1,067,000 Added 18.71%	6,769,000 $0
Q2 2023 Aug 11, 2023	BUY	N/A	1,392,000 Added 32.3%	5,702,000 $0
Q1 2023 May 12, 2023	SELL	N/A	-12,690,000 Reduced 74.65%	4,310,000 $0
Q4 2022 Feb 14, 2023	SELL	N/A	-12,500,000 Reduced 42.37%	17,000,000 $0
Q3 2022 Nov 14, 2022	BUY	N/A	406,000 Added 1.4%	29,500,000 $25.1 Million
Q2 2022 Aug 15, 2022	BUY	N/A	235,000 Added 0.81%	29,094,000 $25.8 Million
Q1 2022 May 13, 2022	BUY	N/A	28,859,000 New	28,859,000 $25.3 Million

Get notified when there are updates to the investment portfolio of Advent Capital Management , based on Form 13F filings with the SEC.

Stay updated on Advent Capital Management with notifications on news.